Dornan David
SEC insider (Form 3/4/5 filer). CIK 0001821353. Chief Scientific Officer at Whitehawk Therapeutics, Inc. (WHWK) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in MORRISTOWN, NJ.
Companies Dornan David has filed insider reports for
- Whitehawk Therapeutics, Inc. (WHWK): Officer, Chief Scientific Officer
- Elevation Oncology, Inc. (ELEV): Officer, CHIEF SCIENTIFIC OFFICER
Dornan David
CIK: 0001821353
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
AwardDirectStock Option (right to buy)
85.9K shares- - Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
AwardDirectRestricted Stock Units
85.9K shares- - Apr 1, 2026WHWK
Whitehawk Therapeutics, Inc.
AwardDirectStock Option (right to buy)
282.3K shares- - Mar 4, 2025AADI
Aadi Bioscience, Inc.
AwardDirectStock Option (right to buy)
688K shares- - Feb 15, 2025ELEV
Elevation Oncology, Inc.
ExerciseDirect9.4K shares- - Feb 15, 2025ELEV
Elevation Oncology, Inc.
Tax PaymentDirect4.2K shares at avg. $0.67$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  WHWK Whitehawk Therapeutics, Inc. | Award Stock Option (right to buy) | 85,887 | - | - | Direct |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award Restricted Stock Units | 85,887 | - | - | Direct |
| Apr 1, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award Stock Option (right to buy) | 282,340 | - | - | Direct |
| Mar 4, 2025 |  AADI Aadi Bioscience, Inc. | Award Stock Option (right to buy) | 687,979 | - | - | Direct |
| Feb 15, 2025 |  ELEV Elevation Oncology, Inc. | Exercise | 9,375 | - | - | Direct |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | Tax Payment | 4,152 | $0.67 | $2,789 | Direct |
1-6 of 6 transactions